Exit Strategies: S1P Signaling and T Cell Migration

Trends in Immunology

Volumn 36, Issue 12, 2015, Pages 778-787

  Baeyens, Audrey ^a   Fang, Victoria ^a   Chen, Cynthia ^a   Schwab, Susan R ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; NONHUMAN; REVIEW; ANIMAL; CELL MOTION; IMMUNOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL MOVEMENT; HOMEOSTASIS; HUMANS; INFLAMMATION; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84949669661     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.10.005     Document Type: Review

References (90)

1. Cyster J.G., Schwab S.R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 2012, 30:69-94.
2. Schwab S.R., Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 2007, 8:1295-1301.
3. Brinkmann V., Lynch K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 2002, 14:569-575.
4. Adachi K., et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppresant, FTY720. Bioorg. Med. Chem. Lett. 1995, 5:853-856.
5. Chiba K., et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 1998, 160:5037-5044.
6. Brinkmann V., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002, 277:21453-21457.
7. Mandala S., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349.
8. Matloubian M., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
9. Allende M.L., et al. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 2004, 279:15396-15401.
10. Schwab S.R., et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 2005, 309:1735-1739.
11. Pappu R., et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316:295-298.
12. Bigaud M., et al. Second generation S1P pathway modulators: research strategies and clinical developments. Biochim. Biophys. Acta 2014, 1841:745-758.
13. Pham T.H., et al. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 2008, 28:122-133.
14. Patrussi L., et al. Enhanced chemokine receptor recycling and impaired S1P1 expression promote leukemic cell infiltration of lymph nodes in chronic lymphocytic leukemia (CLL). Cancer Res. 2015, 75:4153-4163.
15. Nakai A., et al. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors. J. Exp. Med. 2014, 211:2583-2598.
16. Schmidt T.H., et al. CXCR4 promotes B cell egress from Peyer's patches. J. Exp. Med. 2013, 210:1099-1107.
17. Reichardt P., et al. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. EMBO J. 2013, 32:829-843.
18. Willinger T., et al. Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling. J. Exp. Med. 2014, 211:685-700.
19. Sallusto F., et al. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000, 18:593-620.
20. Mueller S.N., et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 2007, 317:670-674.
21. Lund J.M., et al. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320:1220-1224.
22. Yoneyama H., et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 2002, 195:1257-1266.
23. Bankovich A.J., et al. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J. Biol. Chem. 2010, 285:22328-22337.
24. Shiow L.R., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
25. Mudd J.C., et al. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. Blood 2013, 121:2914-2922.
26. Richmond J.M., et al. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells. J. Immunol. 2012, 189:5886-5895.
27. Lepletier A., et al. Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease. PLoS Negl. Trop. Dis. 2014, 8:e3203.
28. Breart B., et al. Lipid phosphate phosphatase 3 enables efficient thymic egress. J. Exp. Med. 2011, 208:1267-1278.
29. Ramos-Perez W.D., et al. A map of the distribution of sphingosine 1-phosphate in the spleen. Nat. Immunol. 2015, (in press). 10.1038/ni.3296.
30. Fukuhara S., et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 2012, 122:1416-1426.
31. Hisano Y., et al. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE 2012, 7:e38941.
32. Mendoza A., et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep. 2012, 2:1104-1110.
33. Nijnik A., et al. The role of sphingosine-1-phosphate transporter spns2 in immune system function. J. Immunol. 2012, 189:102-111.
34. Nagahashi M., et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J. 2013, 27:1001-1011.
35. Christoffersen C., et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9613-9618.
36. Murata N., et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 2000, 352:809-815.
37. St John A.L., et al. S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection. Immunity 2014, 41:440-450.
38. Hor J.L., et al. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4 and CD8 T cell activation to localized viral infection. Immunity 2015, 43:554-565.
39. Braun A., et al. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 2011, 12:879-887.
40. Green J.A., et al. The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat. Immunol. 2011, 12:672-680.
41. Muppidi J.R., et al. Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma. Nature 2014, 516:254-258.
42. Moriyama S., et al. Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers. J. Exp. Med. 2014, 211:1297-1305.
43. Suan D., et al. T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses. Immunity 2015, 42:704-718.
44. Green J.A., Cyster J.G. S1PR2 links germinal center confinement and growth regulation. Immunol. Rev. 2012, 247:36-51.
45. + T follicular helper cell differentiation. Immunity 2015, 42:252-264.
46. Weber J.P., et al. ICOS maintains the T follicular helper cell phenotype by down-regulating Kruppel-like factor 2. J. Exp. Med. 2015, 212:217-233.
47. Kitano M., et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011, 34:961-972.
48. Schenkel J.M., Masopust D. Tissue-resident memory T cells. Immunity 2014, 41:886-897.
49. Carbone F.R. Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs. J. Immunol. 2015, 195:17-22.
50. Iijima N., Iwasaki A. Tissue instruction for migration and retention of T cells. Trends Immunol. 2015, 36:556-564.
51. + tissue-resident memory T cells of skin. Nat. Immunol. 2013, 14:1294-1301.
52. Wakim L.M., et al. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J. Immunol. 2012, 189:3462-3471.
53. Sathaliyawala T., et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2013, 38:187-197.
54. Iijima N., Iwasaki A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 2014, 346:93-98.
55. + T cells. Nat. Immunol. 2013, 14:1285-1293.
56. Mackay L.K., et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 2015, 194:2059-2063.
57. Debes G.F., et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 2005, 6:889-894.
58. Bromley S.K., et al. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 2005, 6:895-901.
59. Gomez D., et al. Effector T cell egress via afferent lymph modulates local tissue inflammation. J. Immunol. 2015, 195:3531-3536.
60. Ledgerwood L.G., et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 2008, 9:42-53.
61. Jenne C.N., et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 2009, 206:2469-2481.
62. Walzer T., et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 2007, 8:1337-1344.
63. Shin H., Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012, 491:463-467.
64. Massberg S., et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131:994-1008.
65. Choi J.W., et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:751-756.
66. Ammit A.J., et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001, 15:1212-1214.
67. Kulakowska A., et al. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. Neurosci. Lett. 2010, 477:149-152.
68. Lai W.Q., et al. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J. Immunol. 2008, 181:8010-8017.
69. Brown M.N., et al. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J. Immunol. 2010, 185:4873-4882.
70. Casey K.A., et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 2012, 188:4866-4875.
71. Wakim L.M., et al. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17872-17879.
72. Schon M.P., et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J. Immunol. 1999, 162:6641-6649.
73. + T cells responding to infection. Nat. Immunol. 2015, 16:406-444.
74. Steinert E.M., et al. Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 2015, 161:737-749.
75. Aspelund A., et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 2015, 212:991-999.
76. Louveau A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015, 523:337-341.
77. Mohammad M.G., et al. Immune cell trafficking from the brain maintains CNS immune tolerance. J. Clin. Invest. 2014, 124:1228-1241.
78. + T helper 1 cell differentiation. Immunity 2012, 37:1091-1103.
79. Ding L., Morrison S.J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013, 495:231-235.
80. Gault C.R., et al. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 2010, 688:1-23.
81. Blaho V.A., et al. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 2015, 523:342-346.
82. Galvani S., et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci. Signal. 2015, 8:ra79.
83. Lee Y.M., et al. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat. 2007, 84:154-162.
84. Lee M.J., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998, 279:1552-1555.
85. Liu C.H., et al. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol. Biol. Cell 1999, 10:1179-1190.
86. Lo C.G., et al. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 2005, 201:291-301.
87. MacDonald I.C., et al. The high splenic hematocrit: a rheological consequence of red cell flow through the reticular meshwork. Microvasc. Res. 1991, 42:60-76.
88. Kono M., et al. Sphingosine-1-phosphate receptor 1 reporter mice reveal receptor activation sites in vivo. J. Clin. Invest. 2014, 124:2076-2086.
89. Sanna M.G., et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol. 2006, 2:434-441.
90. Camerer E., et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 2009, 119:1871-1879.